News

211, 2015

VLP Therapeutics to Present at International Conference on Vaccines R&D 2015

2015.11.02|

VLP Therapeutics, LLC. (“VLP”) announced that its Chief Executive Officer, Dr. Wataru Akahata, will present at the International Conference on Vaccines Research and Development 2015 on Tuesday, November 3, 2015, at 4:00 p.m. Eastern Time. The event will take place at the DoubleTree by Hilton Baltimore-BWI Airport in Linthicum, Maryland.

406, 2015

VLP Therapeutics to Initiate Collaboration with National Cancer Center in Japan

2015.06.04|

VLP Therapeutics, LLC. (“VLP”) announced that it has initiated a research collaboration with the National Cancer Center’s National Cancer Center Research Institute in Japan. The collaboration will help facilitate VLP’s research and development of cancer vaccine candidates.

406, 2015

VLP Therapeutics to Initiate Collaboration with Johns Hopkins University Bloomberg School of Public Health

2015.06.04|

VLP Therapeutics, LLC. (“VLP”) announced that it has initiated a research collaboration with John’s Hopkins University Bloomberg School of Public Health to research VLP’s malaria vaccine candidates.

104, 2015

VLP Therapeutics Enters Collaboration with Institute of Tropical Medicine, Nagasaki University

2015.04.01|

VLP Therapeutics, LLC. (“VLP”) announced that it has entered into a research collaboration with the Institute of Tropical Medicine at Nagasaki University in Japan. The collaboration will facilitate VLP’s research and development of dengue vaccine candidates.